A synbiotic mixture of scGOS/lcFOS and Bifidobacterium breve M-16V increases faecal Bifidobacterium in healthy young children

被引:7
|
作者
Kosuwon, P. [1 ]
Lao-Araya, M. [2 ]
Uthaisangsook, S. [3 ]
Lay, C. [4 ]
Bindels, J. [4 ]
Knol, J. [5 ,6 ]
Chatchatee, P. [7 ]
机构
[1] Khon Kaen Univ, Fac Med, Dept Paediat, 123 Mittrapab Rd, Khon Kaen 40002, Thailand
[2] Chiang Mai Univ Hosp, 110 Suthep Rd Tambon Su Thep, Chiang Mai 50200, Thailand
[3] Naresuan Univ, Fac Med, Dept Paediat, 99 Moo 9,9,Phitsanulok Nakhon Sawan Rd, Mueang Phitsanulok 65000, Phitsanulok, Thailand
[4] Danone Nutricia Res, 30 Biopolis St,05-01B, Singapore 138671, Singapore
[5] Danone Nutricia Res, Utrecht, Netherlands
[6] Wageningen Univ, Lab Microbiol, POB 7005, NL-6700 CA Wageningen, Netherlands
[7] King Chulalongkorn Mem Hosp, 1873,Rama 4 Rd, Bangkok 10330, Thailand
关键词
healthy toddlers; gut microbiota; synbiotic; Bifidobacterium; stool consistency; IN-SITU HYBRIDIZATION; CHAIN FATTY-ACIDS; GUT MICROBIOTA; ATOPIC-DERMATITIS; INFANTS; BACTERIA; OLIGOSACCHARIDES; FORMULA; INTERPLAY; RESPONSES;
D O I
10.3920/BM2017.0110
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Little is known about the impact of nutrition on toddler gut microbiota. The plasticity of the toddler gut microbiota indicates that nutritional modulation beyond infancy could potentially impact its maturation. The objective of this study was to determine the effect of consuming Young Child Formula (YCF) supplemented with short chain galactooligosaccharides and long chain fructooligosaccharides (scGOS/lcFOS, ratio 9:1) and Bifidobacterium breve M-16V on the development of the faecal microbiota in healthy toddlers. A cohort of 129 Thai children aged 1-3 years were included in a randomised controlled clinical study. The children were assigned to receive either YCF with 0.95 g/100 ml of scGOS/lcFOS and 1.8x107 cfu/g of B. breve M-16V (Active-YCF) or Control-YCF for 12 weeks. The composition and metabolic activity of the faecal microbiota, and the level of secretory immunoglobulin A were determined in the stool samples. The consumption of Active-YCF increased the proportion of Bifidobacterium (mean 27.3% at baseline to 33.3%, at week 12, P=0.012) with a difference in change from baseline at week 12 between the Active and Control of 7.48% (P=0.030). The consumption of Active-YCF was accompanied with a more acidic intestinal milieu compared to the Control-YCF. The pH value decreased statistically significantly in the Active-YCF group from a median of 7.05 at baseline to 6.79 at week 12 (P<0.001). The consumption of Active-YCF was associated with a softer pudding-like stool consistency compared to the Control-YCF. At week 6 and week 12, the between-group difference in stool consistency was statistically significant (P=0.004 and P<0.001, respectively). A Young Child Formula supplemented with scGOS/lcFOS and B. breve M-16V positively influences the development of the faecal microbiota in healthy toddlers by supporting higher levels of Bifidobacterium. The synbiotic supplementation is also accompanied with a more acidic intestinal milieu and softer stools.
引用
收藏
页码:541 / 552
页数:12
相关论文
共 36 条
  • [21] Dietary, nondigestible oligosaccharides and Bifidobacterium breve M-16V suppress allergic inflammation in intestine via targeting dendritic cell maturation
    de Kivit, Sander
    Kostadinova, Atanaska I.
    Kerperien, JoAnn
    Morgan, Mary E.
    Muruzabal, Veronica Ayechu
    Hofman, Gerard A.
    Knippels, Leon M. J.
    Kraneveld, Aletta D.
    Garssen, Johan
    Willemsen, Linette E. M.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2017, 102 (01) : 105 - 115
  • [22] Suppressive Effects of Bifidobacterium breve Strain M-16V on T-Helper Type 2 Immune Responses in a Murine Model
    Inoue, Yumi
    Iwabuchi, Noriyuki
    Xiao, Jin-zhong
    Yaeshima, Tomoko
    Iwatsuki, Keiji
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2009, 32 (04) : 760 - 763
  • [23] Effect of Bifidobacterium breve M-16V Supplementation on Fecal Bifidobacteria in Preterm Neonates - A Randomised Double Blind Placebo Controlled Trial
    Patole, Sanjay
    Keil, Anthony D.
    Chang, Annie
    Nathan, Elizabeth
    Doherty, Dorota
    Simmer, Karen
    Esvaran, Meera
    Conway, Patricia
    PLOS ONE, 2014, 9 (03):
  • [24] Post-sensitization administration of non-digestible oligosaccharides and Bifidobacterium breve M-16V reduces allergic symptoms in mice
    van Esch, Betty C. A. M.
    Abbring, Suzanne
    Diks, Mara A. P.
    Dingjan, Gemma M.
    Harthoorn, Lucien F.
    Vos, A. Paul
    Garssen, Johan
    IMMUNITY INFLAMMATION AND DISEASE, 2016, 4 (02): : 155 - 165
  • [25] A combination of fructo-oligosaccharides and Bifidobacterium breve M-16V suppresses airway resistance and inflammation in house dust mite allergic mice
    Verheijden, K. A. T.
    Willemsen, L. E. M.
    Braber, S.
    Garssen, J.
    Kraneveld, A. D.
    Folkerts, G.
    ALLERGY, 2014, 69 : 467 - 468
  • [26] Colonization of Supplemented Bifidobacterium breve M-16V in Low Birth Weight Infants and Its Effects on Their Gut Microbiota Weeks Post-administration
    Horigome, Ayako
    Hisata, Ken
    Odamaki, Toshitaka
    Iwabuchi, Noriyuki
    Xiao, Jin-zhong
    Shimizu, Toshiaki
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [27] Bifidobacterium breve M-16V regulates the autonomic nervous system via the intestinal environment: A double-blind, placebo-controlled study
    Mutoh, Natsumi
    Moriya, Masamichi
    Xu, Chendong
    Kato, Kumiko
    Arai, Satoshi
    Iwabuchi, Noriyuki
    Tanaka, Miyuki
    Yin, Jinghua
    Itamura, Ronko
    Sakatani, Kaoru
    Warisawa, Shinichi
    BEHAVIOURAL BRAIN RESEARCH, 2024, 460
  • [28] Maternal supplementation with Bifidobacterium breve M-16V prevents their offspring from allergic airway inflammation accelerated by the prenatal exposure to an air pollutant aerosol
    Terada-Ikeda, Chiyoko
    Kitabatake, Masahiro
    Hiraku, Akari
    Kato, Kumiko
    Yasui, Satsuki
    Imakita, Natsuko
    Ouji-Sageshima, Noriko
    Iwabuchi, Noriyuki
    Hamada, Kaoru
    Ito, Toshihiro
    PLOS ONE, 2020, 15 (09):
  • [29] A synbiotic mixture of Bifidobacterium breve M16-V, oligosaccharides and pectin, enhances Short Chain Fatty Acid production and improves lung health in a preclinical model for pulmonary neutrophilia
    Bezemer, Gillina F. G.
    Diks, Mara A. P.
    Mortaz, Esmaeil
    van Ark, Ingrid
    van Bergenhenegouwen, Jeroen
    Kraneveld, Aletta D.
    Folkerts, Gert
    Garssen, Johan
    FRONTIERS IN NUTRITION, 2024, 11
  • [30] Probiotic characteristics and in vitro compatibility of a combination of Bifidobacterium breve M-16 V, Bifidobacterium longum subsp infantis M-63 and Bifidobacterium longum subsp longum BB536
    Toscano, Marco
    De Vecchi, Elena
    Gabrieli, Arianna
    Zuccotti, Gian Vincenzo
    Drago, Lorenzo
    ANNALS OF MICROBIOLOGY, 2015, 65 (02) : 1079 - 1086